Hunan Nucien Pharmaceutical Co (SHSE:688189) Other Net Income (Loss) : ¥0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Hunan Nucien Pharmaceutical Co Other Net Income (Loss)?

Hunan Nucien Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Mar. 2025 was ¥0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.0 Mil.

Hunan Nucien Pharmaceutical Co's quarterly Other Net Income (Loss) stayed the same from Sep. 2024 (¥0.0 Mil) to Dec. 2024 (¥0.0 Mil) but then increased from Dec. 2024 (¥0.0 Mil) to Mar. 2025 (¥0.0 Mil).

Hunan Nucien Pharmaceutical Co's annual Other Net Income (Loss) declined from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥-0.0 Mil) but then increased from Dec. 2023 (¥-0.0 Mil) to Dec. 2024 (¥0.0 Mil).

Hunan Nucien Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Hunan Nucien Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Nucien Pharmaceutical Co Other Net Income (Loss) Chart

Hunan Nucien Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Hunan Nucien Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Hunan Nucien Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Hunan Nucien Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Hunan Nucien Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Nucien Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hunan Nucien Pharmaceutical Co Ltd (SHSE:688189) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100

Website

http://www.nucien.com

Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields.

Hunan Nucien Pharmaceutical Co Headlines

No Headlines